- Joined
- Aug 5, 2021
If you don't give bullies an inch why you post this easily mocked selfie bro
Off-Topic Transgender Legislation and Litigation
- Thread starter Not Dr. Evil
- Start date
-
🐕 I am attempting to get the site runnning as fast as possible. If you are experiencing slow page load times, please report it.
- Joined
- Jan 2, 2025
"Then what makes them trans?"
Nobody Important
kiwifarms.net
- Joined
- Aug 6, 2021
HHS report is out. Copium, sneedium, and dilatium are forthcoming.
- Joined
- Jan 31, 2015
- Joined
- Aug 13, 2024
Based on the summary, it sounds like a "More Research Needed" type of report rather than a real hammer drop. However, there are some standout paragraphs like:
- Joined
- Jun 23, 2021
It's almost three hundred pages not including the hundred-plus page bibliography, but the table of contents itself is highly encouraging. Will have to peruse the actual docs later. Seems like winning at first glance.
Nero Fiddled
kiwifarms.net
- Joined
- Dec 30, 2022
Only skimmed through it quickly, but the last paragraph speaks volumes:
"While no clinician or medical association intends to fail their patients—particularly those who are most vulnerable—the preceding chapters demonstrate that this is precisely what has occurred."
diroama
kiwifarms.net
- Joined
- Dec 28, 2019
The English and Scottish football associations have banned troons from playing women's football.
- Joined
- Mar 11, 2016
Take your Ws where you can: "We don't know if these treatments work and here's why" is much harder to spin as a hit piece and still provides enough for insurers to reduce or deny coverage on the grounds these are not proven treatments.
- Joined
- Jul 9, 2021
Quote text isn’t working idk but this one will make them seethe, and I can already hear the indignant screeching.
“there is no evidence that pediatric medical transitionreduces the incidence of suicide, which remains, fortunately, very low”
Only a nihilistic death cult would object to this but they will insist that mass childhood suicides are being covered up, and that’s why you need to mutilate your child now now now.
- Joined
- Dec 23, 2022
Al, you ignorant slut. It’s not propaganda if it’s true.
- Joined
- Dec 19, 2022
Democrats reintroduce landmark LGBTQ nondiscrimination bill
The Equality Act is back. https://archive.ph/X95RYDemonstrating once again that the Democrats are:
1) incredibly oblivious
2) incredibly stubborn
3) a death cult
It won't get any traction now. It's just a virtue signalling reaction to Pam Bondi and Co turning their attention to "trans healthcare" for minors: https://archive.ph/lihbw
Not Dr. Evil
kiwifarms.net
- Joined
- Dec 31, 2022
- Joined
- Jan 2, 2025
Summary of the "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices" Report
- Title: Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices
- Authors: Department of Health and Human Services (specific individual authors not listed)
- Date: May 1, 2025
- Peer-Review Status: Not explicitly stated as peer-reviewed; commissioned pursuant to Executive Order 14187, signed on January 28, 2025, and intended for policymakers, clinicians, therapists, medical organizations, patients, and families.
- Publisher: Department of Health and Human Services
- Document Type: Comprehensive review (not a clinical practice guideline or legislative/policy recommendation)
Overview
This report, published by the U.S. Department of Health and Human Services, critically evaluates the evidence, clinical practices, and ethical considerations surrounding the treatment of pediatric gender dysphoria (GD). It focuses on children and adolescents experiencing distress related to their sex or associated social expectations, explicitly excluding adult treatment. The review highlights the controversial nature of pediatric gender medicine (PGM), particularly the "gender-affirming" model, and contrasts U.S. practices with international shifts toward more cautious, psychotherapeutic approaches.
Breakdown of Findings and Implications
Part I: Background
- Context and Definitions:
- Gender dysphoria (GD) is defined as distress related to one's sexed body or social expectations associated with sex, distinct from non-conformity to sex-role stereotypes (e.g., "tomboyism" or "sissyish" behavior), which is not pathological.
- The U.S. has seen a rise in transgender identification, with 3.3% of adolescents identifying as transgender and 2.2% questioning their gender (as of 2023 data). Between 2016–2020, 3,215 adolescents (ages 12–1
underwent surgical breast/chest procedures, and by 2018–2022, 0.1% of 17-year-olds were on cross-sex hormones.
- The "gender-affirming" model, endorsed by WPATH, the Endocrine Society (ES), and the American Academy of Pediatrics (AAP), involves social affirmation, puberty blockers (PBs) at Tanner Stage 2 (as early as age 8–9), cross-sex hormones (CSH), and surgeries (e.g., mastectomy).
- Historical Evolution:
- The medicalized approach to pediatric GD originated with the Dutch Protocol in the 1990s, initially an experimental research protocol that claimed mental health benefits based on a small study. It was rapidly adopted internationally as standard practice.
- The U.S. adopted this model, but recent international trends (e.g., in the UK, Finland, Sweden) have seen a retreat from medical interventions due to new evidence and concerns about risks.
- International Reversals:
- The Cass Review (UK, 2024) and other systematic reviews prompted countries like the UK to ban routine use of PBs for GD, citing weak evidence for benefits and significant risks.
- Reasons for reversals include epidemiological shifts (e.g., increased prevalence of GD, more female adolescents, nonbinary identities), mental health comorbidities, social influence, unclear natural history (most cases resolve without intervention), treatment risks, and lack of reliable evidence of benefit.
- Many countries now recommend psychosocial approaches over hormonal or surgical interventions as the primary treatment for pediatric GD.
- Terminology Concerns:
- The report critiques the language in PGM, such as "gender-affirming care" and "top surgery," for being misleading and presupposing ethical conclusions. It emphasizes the need for scientifically accurate, neutral terminology to avoid obscuring the invasive nature of treatments on children.
Part II: Evidence Review
- Methodology:
- The review conducted an "umbrella review" of systematic reviews (SRs) to assess the benefits and harms of interventions (social transition, PBs, CSH, surgeries, psychotherapy) for pediatric GD.
- Evidence quality was rated as "very low" for psychological outcomes, quality of life, regret, and long-term health, indicating that reported benefits are likely overstated.
- Findings on Interventions:
- Social Transition: Evidence on outcomes is sparse and of low quality, with uncertainty about long-term effects.
- Puberty Blockers (PBs): No robust evidence of mental health benefits; risks include impaired bone density, potential adverse cognitive impacts, and infertility if followed by CSH.
- Cross-Sex Hormones (CSH): Limited evidence of benefit; risks include cardiovascular and metabolic disorders, sexual dysfunction, and psychiatric effects.
- Surgeries: Outcomes data is scarce; risks include surgical complications, regret, and issues from early pubertal blockade (e.g., insufficient tissue for later procedures like vaginoplasty).
- Psychotherapy: No evidence of harm; a viable noninvasive alternative, though under-researched due to mischaracterization as "conversion therapy."
- Harms: Risks are significant and include infertility, sexual dysfunction, bone health issues, cardiovascular/metabolic disorders, adverse psychiatric effects, and regret. The lack of systematic harm tracking in studies contributes to uncertainty.
- Implications:
- The evidence base for pediatric medical transition is weak, with potential harms outweighing uncertain benefits. The report calls for a reevaluation of the "gender-affirming" model in light of these findings.
Part III: Clinical Realities
- Guideline Quality:
- WPATH and ES guidelines, widely followed in the U.S., were found to lack developmental rigor and transparency in a systematic review of international guidelines. They are not recommended for clinical use.
- WPATH’s Standards of Care, Version 8 (SOC-
- High-quality guidelines from Finland, Sweden, and the UK recommend psychosocial interventions over medical ones, emphasizing comprehensive assessments.
- U.S. Clinical Practices:
- U.S. gender clinics often deviate from even the relaxed SOC-8 criteria, with assessments as short as two hours (e.g., at Boston Children’s Hospital, Children’s Hospital Los Angeles, UCSF Benioff). Some clinics, like Planned Parenthood, provide hormones with minimal evaluation.
- The "gender-affirming" model in the U.S. is child-led, prioritizing "embodiment goals" over thorough mental health assessments, increasing risks of iatrogenic harm.
- Whistleblowers:
- Clinicians like Laura Edwards-Leeper, Erica Anderson, Jamie Reed, Tamara Pietzke, and Eithan Haim have raised concerns about inadequate assessments, rushed treatments, and harm to patients. Their voices have been dismissed by advocates of medical transition.
- Medical Associations:
- U.S. medical associations (e.g., AMA, AAP) project a false consensus on pediatric medical transition, driven by small, WPATH-influenced committees. Dissent within these organizations has been suppressed, stifling open debate.
Part IV: Ethical Considerations
- Autonomy vs. Nonmaleficence:
- While patient autonomy is critical, it does not override clinicians’ duties of nonmaleficence (do no harm) and beneficence (promote well-being). Offering interventions with uncertain benefits and significant risks violates these principles.
- The report argues that pediatric medical transition, given its risks and lack of evidence, should not be offered even if requested, as it reduces medicine to consumerism and undermines trust in medical authority.
- Regret and Research Ethics:
- The true rate of regret is unknown due to poor data collection, but its existence is significant. Regret alone does not determine the appropriateness of an intervention, but the potential for iatrogenic harm is a major concern.
- High-quality research (e.g., randomized controlled trials) on PBs or CSH may be ethically problematic due to the experimental nature of these treatments and potential harms to minors.
Part V: Psychotherapy
- Mental Health Context:
- The rise in pediatric GD coincides with a broader youth mental health crisis. Many GD patients have comorbidities (e.g., depression, anxiety, autism), which are independently associated with suicidal ideation.
- No evidence supports an independent link between GD and suicidality, nor does medical transition reduce suicide rates, which remain low.
- Psychotherapy as an Alternative:
- Psychotherapy is a noninvasive, evidence-supported option for managing GD and comorbidities, with no documented adverse effects in this context.
- Its underuse in the U.S. stems from fears of being labeled "conversion therapy," a mischaracterization that has stifled research and application.
Key Implications
- For Clinicians and Policymakers:
- The report urges a shift away from the "gender-affirming" model in the U.S., advocating for psychosocial interventions as the first line of treatment, in line with international trends.
- It calls for improved guideline development, stricter adherence to evidence-based medicine (EBM), and better data collection on outcomes, including regret and harms.
- For Patients and Families:
- Families are caught in a polarized debate and require accurate, evidence-based information. The report emphasizes the risks of irreversible interventions and the potential for natural resolution of GD without medical treatment.
- For the Medical Community:
- The report highlights the need for open debate, transparency in guideline development, and protection of whistleblowers. It critiques the role of medical associations in perpetuating a false consensus and suppressing dissent.
- Ethical and Social Considerations:
- The report underscores the ethical responsibility to prioritize nonmaleficence and beneficence over patient demands for unproven treatments, especially in pediatrics, where consent and long-term consequences are complex.
Conclusion
The "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices" report reveals a field marked by weak evidence, significant risks, and ethical concerns. It challenges the U.S. reliance on the "gender-affirming" model, advocating for a cautious, psychotherapeutic approach aligned with international trends. The findings underscore the need for rigorous research, transparent clinical practices, and a commitment to ethical principles to ensure the well-being of children and adolescents with gender dysphoria.
- Joined
- Aug 5, 2021
Its prefaced by literally saying wpath deleted it....
diroama
kiwifarms.net
- Joined
- Dec 28, 2019
English netball and cricket has followed football in banning troons.
I cannot cope with this much winning.
I cannot cope with this much winning.
Izdaja Slika
kiwifarms.net
- Joined
- May 18, 2024
The Australian federal elections are on tomorrow, but there has been pre-poll voting going on for a week or so.
Rebel News interviewed Zoe Daniel, who does not belong to one of the two major parties but is a Climate 200-funded teal MP. In this election, she is very likely to retain her seat in parliament. In the interview, she calmly lists the things she is proud of in the 'gender equality' space and the advances she's made for women.
Then the interviewer asked her 'what is a woman?' and she responded with 'this interview is over'.
As the rest of the Anglosphere has little victories, Australia stays firmly ensconced in trans madness.
Rebel News interviewed Zoe Daniel, who does not belong to one of the two major parties but is a Climate 200-funded teal MP. In this election, she is very likely to retain her seat in parliament. In the interview, she calmly lists the things she is proud of in the 'gender equality' space and the advances she's made for women.
Then the interviewer asked her 'what is a woman?' and she responded with 'this interview is over'.
As the rest of the Anglosphere has little victories, Australia stays firmly ensconced in trans madness.
- Joined
- Jul 31, 2020
Haven't academics openly been using software to generate citations for decades? I doubt that this is ChatGPT, but even if it is, how is this substantively different than Son of Citation Machine? It's a little odd to put an error page as the title of the webpage, but when your point is specifically that the document was deleted then it makes sense.
- Joined
- Aug 5, 2021
It's awkwardly worded I'll give them that but the intent is clear
- Joined
- Feb 14, 2023
Maybe. Perhaps we haven’t gone as far. Zoe Daniels is a crossbencher, and her ability to do anything is limited. She’s also in Victoria, a totally brain damaged, pozzed state, so she has to say stupid shit like that. The Federal Government is Labor, so leftwing, but it hasn’t subsidised wide-scale SRS and our troons ‘n’ poons usually have to pay for butchery overseas, and that’s not about to change. Corporates are pretty pozzed, as is the mainstream media, but the general population? The (female) youth is pozzed, but young men aren’t. Our compulsory voting system usually forces governments to the centre. I’m not complacent, but am quietly optimistic.